Oxidants vs. Carbon Dioxide: What Happens When Alveoli Experience Hypoxic Stress?

By

The tiny air sacs of the lungs, known as alveoli, are where life-sustaining gas exchange occurs. Under normal conditions, oxygen moves from the inhaled air into the bloodstream, while carbon dioxide (CO₂), a normal waste product of metabolism, diffuses from the blood into the alveoli and is exhaled. This delicate exchange depends on healthy alveolar cells, an intact blood-air barrier, and pulmonary surfactant that keeps the alveoli open.

When the alveoli are subjected to hypoxic stress—a state in which they receive insufficient oxygen—the lungs undergo a profound biological response that extends far beyond impaired oxygen exchange. Rather than simply producing more carbon dioxide, hypoxic alveoli activate inflammatory signaling pathways that generate large amounts of reactive oxygen species (ROS), commonly referred to as oxidants or free radicals.

Hypoxia Triggers an Oxidative Stress Response

Paradoxically, oxygen deprivation often increases oxidative damage. As oxygen levels decline, mitochondria become dysfunctional and immune cells, including neutrophils and macrophages, are recruited to the injured lung tissue. These cells produce reactive oxygen species such as:

  • Superoxide (O₂•⁻)
  • Hydrogen peroxide (H₂O₂)
  • Hydroxyl radicals (•OH)
  • Peroxynitrite (ONOO⁻)

Under normal circumstances, these oxidants help destroy invading microorganisms. However, during severe hypoxia or lung injury, excessive ROS production overwhelms the body's antioxidant defenses, resulting in oxidative stress. Instead of protecting the lungs, these molecules begin damaging healthy alveolar cells, proteins, lipids, surfactant, and DNA.

Sticky Alveoli and Surfactant Failure

One of the earliest consequences of oxidative injury is damage to Type II alveolar epithelial cells, which produce pulmonary surfactant. Surfactant lowers surface tension inside the alveoli, allowing them to remain open during exhalation.

When oxidative stress destroys these cells:

  • Surfactant production decreases.
  • Surface tension rises.
  • Alveoli become unstable and "sticky."
  • Air sacs collapse during exhalation (atelectasis).
  • Reopening collapsed alveoli requires much greater breathing effort.

This creates a vicious cycle in which collapsed alveoli receive even less oxygen, leading to worsening hypoxia and further oxidant production.

Oxidants vs. Carbon Dioxide: Understanding the Difference

A common misconception is that damaged lungs begin exhaling oxidants instead of carbon dioxide. In reality, these substances have very different origins and behaviors.

Carbon dioxide (CO₂) is the normal end product of cellular metabolism. Healthy lungs continuously remove CO₂ from the bloodstream and eliminate it through exhalation. Although carbon dioxide levels may rise if ventilation becomes severely impaired, CO₂ itself is not a marker of oxidative lung injury.

Reactive oxygen species (oxidants) are highly unstable molecules generated within injured lung tissue. Because ROS exist for only fractions of a second, they do not travel through the airways to be exhaled in significant amounts. Instead, they react immediately with nearby cellular structures, causing local tissue damage.

What Is Actually Detected in Exhaled Breath?

Although reactive oxygen species themselves are too unstable to be measured directly in exhaled breath, they initiate lipid peroxidation, a destructive process in which oxidants attack cell membranes. This reaction generates numerous volatile organic compounds (VOCs) and carbonyl compounds, including aldehydes and ketones.

These oxidized molecules can be detected in exhaled breath and serve as indirect biomarkers of oxidative stress. Researchers have demonstrated that patients with acute lung injury, acute respiratory distress syndrome (ARDS), and severe COVID-19 often produce a distinctive breath profile characterized by elevated concentrations of oxidative metabolites.

Thus, while patients continue to exhale normal respiratory gases such as oxygen, nitrogen, and carbon dioxide, their breath may also contain measurable chemical fingerprints of oxidative damage rather than reactive oxygen species themselves.

COVID-19 as an Example of Hypoxic Oxidative Injury

COVID-19 provided a striking example of how hypoxic stress can amplify oxidative injury within the lungs. SARS-CoV-2 infects Type II alveolar cells through ACE2 receptors, reducing surfactant production and promoting alveolar collapse. Simultaneously, the intense inflammatory response recruits immune cells that release large quantities of reactive oxygen species.

The result is a self-perpetuating cycle:

  1. Viral injury damages alveolar cells.
  2. Surfactant production declines.
  3. Alveoli collapse and oxygen exchange worsens.
  4. Tissue hypoxia develops.
  5. Immune cells release excessive oxidants.
  6. Oxidative damage further destroys alveolar tissue.
  7. Gas exchange deteriorates even further.

This combination of hypoxia, inflammation, oxidative stress, and surfactant failure contributes to the severe respiratory distress observed in advanced viral pneumonia and ARDS.

The Importance of Oxidative Stress in Lung Disease

Oxidative stress is now recognized as a central mechanism in many pulmonary disorders, including pneumonia, ARDS, COPD, pulmonary fibrosis, and severe viral infections. While carbon dioxide reflects ventilation, oxidant production reflects cellular injury and inflammation.

Understanding the distinction is important: carbon dioxide is a normal waste gas eliminated through breathing, whereas reactive oxygen species are damaging molecules produced within injured lung tissue. Their effects are largely local, but the chemical byproducts they create can be detected in exhaled breath and may provide valuable insight into the severity of lung injury and ongoing inflammation.

References:

COVID-19 and the lungs: A review
https://www.sciencedirect.com/science/article/pii/S1876034121003154

Alveolar Type II Cells and Pulmonary Surfactant in COVID-19 Era
https://pmc.ncbi.nlm.nih.gov/articles/PMC8884364/

Mechanisms of Hypoxia in COVID-19 Patients: A Pathophysiologic Reflection
https://pmc.ncbi.nlm.nih.gov/articles/PMC7689135/

Coronavirus Pandemic Update 65: COVID-19 and Oxidative Stress (Prevention & Risk Factors)
https://www.youtube.com/watch?v=gzx8LH4Fjic&t=118s

Evaluation of Oxidative Stress and Endothelial Dysfunction in COVID-19 Patients
https://www.mdpi.com/1648-9144/60/7/1041


© 2000-2030 Sieglinde W. Alexander. All writings by Sieglinde W. Alexander have a fife year copy right.
Library of Congress Card Number: LCN 00-192742 ISBN: 0-9703195-0-9 

Comments

Post a Comment

Popular posts from this blog

Schnitzler Syndrome: A Rare Autoinflammatory Disorder

By
Schnitzler syndrome is a rare, chronic autoinflammatory disease characterized by chronic urticaria (hives), recurrent fever, joint pain, and monoclonal gammopathy (abnormal proteins in the blood). First described by Dr. Liliane Schnitzler in 1972 , this condition is often misdiagnosed, leading to years of untreated symptoms before a correct diagnosis is made. The case report, " A 58-Year-Old Woman With Urticaria, Fever, and Joint Pain " , describes a case that closely aligns with my own experience with this challenging disorder. Key Features of Schnitzler Syndrome Schnitzler syndrome presents with a characteristic set of symptoms, though not all patients experience them in the same way: Chronic Urticaria (Hives) – Persistent, non-itchy or mildly itchy red patches that do not respond to antihistamines. Monoclonal Gammopathy (IgM or IgG type) – Abnormal monoclonal immunoglobulin detected in the blood (most commonly IgM ). Recurrent Fever – Unexplained fever episodes, often...
Read more

Dysferlin Protein: Key Roles, Genetic Locations

By
Image
The purpose of this article is to share and discuss the details of a new discovery, which is highlighted within: CRISPR-Cas9: A Breakthrough Tool to Repair the DYSF Gene The dysferlin protein plays an essential role in maintaining the integrity of muscle cell membranes, particularly in tissues that endure significant mechanical stress, such as skeletal and cardiac muscles . Encoded by the DYSF gene , dysferlin is indispensable for repairing damaged cell membranes after injury caused by muscle contraction or external forces. This article explores the main locations where dysferlin is produced, its role in muscle repair, and supportive nutritional and therapeutic strategies for individuals with dysferlin deficiency, such as those affected by dysferlinopathies (e.g., Limb-Girdle Muscular Dystrophy Type 2B or Miyoshi Myopathy). Currently, there is no definitive answer as to why the severity of dysferlin protein expression or depletion varies. Do pathogens play a role in the methylation o...
Read more

Acute Flaccid Myelitis (AFM): Understanding the “Polio-like” Illness Affecting the Spinal Cord

By
Acute flaccid myelitis (AFM) is a rare but serious neurological disorder that primarily affects children and results in sudden weakness or paralysis in the limbs. Often referred to as a “polio-like” illness, AFM has drawn growing attention over the past decade due to its similarities with poliomyelitis and its seasonal spikes in reported cases. While AFM remains uncommon, its potential severity—and the uncertainty surrounding its causes—make it an important condition for clinicians, parents, and public health officials to understand. What Is Acute Flaccid Myelitis? AFM is a condition that affects the gray matter of the spinal cord , where it damages motor neurons responsible for muscle movement. This leads to acute, flaccid paralysis , meaning muscles become limp and weak, often without warning. The condition can progress rapidly, and in some cases, the weakness can become long-lasting or even permanent. Although its symptoms resemble those of poliovirus infection, AFM is not cau...
Read more

Very Long-Chain Fatty Acids (VLCFAs) X-ALD and Spinal Muscular Atrophy (SMA): Exploring the Connection

By
Image
Introduction: White Brain Matter, VLCFAs, and X-ALD X-linked Adrenoleukodystrophy (X-ALD) is a rare inherited metabolic disorder and a major cause of progressive neurodegeneration in children—sometimes referred to as “childhood dementia.” Across related conditions, prevalence can range from approximately 1 in 2,000 to 1 in 500,000 newborns. Among its forms, childhood cerebral X-ALD is the most severe, marked by rapid inflammatory demyelination in the brain and often fatal outcomes if not treated early. At the core of X-ALD is a disruption in the metabolism of Very Long-Chain Fatty Acids (VLCFAs). Normally, these fatty acids are broken down in peroxisomes—specialized structures within cells that help maintain metabolic balance. In X-ALD, a mutation in the ABCD1 gene impairs this function, causing VLCFAs to accumulate, particularly in the white matter of the brain, spinal cord, and adrenal glands. This accumulation leads to demyelination, adrenal insufficiency (Addison’s disease), an...
Read more

Toxic Skin Condition Post-mRNA COVID-19 Vaccination

By
Image
Important update: My experiences have now been formally verified following several years of dismissal. Vasculitis syndromes: the pathogenic roles of COVID-19 and related vaccinations https://link.springer.com/article/10.1186/s12985-025-03032-x  ----------------------------------------- Identifying Severe Skin Conditions Post-Vaccination Following administration of the BioNTech mRNA vaccine, a small subset of individuals may develop severe and complex reactions. These reactions are often misdiagnosed or misunderstood due to their rarity and diverse presentation. This essay examines a case characterized by severe skin conditions, systemic symptoms, and complications such as hypercalcemia and crystal formation. It highlights the need for accurate diagnosis, holistic management, and increased awareness of these rare but significant vaccine-related adverse events. Initial Symptoms and Misdiagnoses Severe symptoms began shortly after the first dose of the BioNTech vaccine, initially pres...
Read more

Is ME CFS connected to Spinal Muscular Atrophy (SMA) or Post Polio?

By
Today, I understand why Spinal Muscular Atrophy (SMA) received little attention, particularly in the mid-50s. This complex and debilitating genetic illness was poorly understood, and patients' symptoms were often minimized or even dismissed. For more information, please visit the Spinal Muscular Atrophy (SMA) page on MalaCards . Even now, many neurologists lack detailed knowledge of SMA, and comprehensive examinations mentioned in research are rarely pursued. In 2008, while investigating permanent adrenal insufficiency, an MRI ordered by my endocrinologist unexpectedly revealed Chiari Malformation II. However, surgery in 2009 brought no improvement. In 2010, a DNA test showed a genetic marker in the ACTN3 gene: https://www.malacards.org/search/results?q=ACTN3%20gene%20and%20Spinal%20Muscular%20Atrophy%20(SMA) A 2015 MRI revealed ankylosing spondylitis, multiple Tarlov cysts, stenosis at L4 and L5, spinal canal narrowing, and widespread degenerative changes. Surgery on L4 and L5 ...
Read more

Polio and Post-Polio Syndrome (PPS): Summary and Key Insights

By
Image
  Abstract To investigate the possible role of poliovirus (PV) infection in the development of Post-Polio Syndrome (PPS), researchers studied serum, cerebrospinal fluid (CSF), peripheral blood lymphocytes, and muscle tissue from 47 PPS patients. Elevated IgM antibodies against poliovirus were identified in a subset of patients, with titers reaching 1:250 compared with less than 1:50 in healthy individuals and disease controls. Using polymerase chain reaction (PCR) techniques targeting the poliovirus replicase gene, PV RNA sequences were detected in peripheral blood lymphocytes from 7 of 37 patients and in the CSF of 4 of 40 patients, while no viral sequences were detected in controls. Sequencing confirmed a 99.3% homology with poliovirus type 1. These findings suggest that some PPS patients may exhibit an ongoing immune response to poliovirus antigens. The detection of poliovirus RNA raises the possibility of persistent mutated virus or defective viral particles. However, the signi...
Read more

Cytokine Storm, Mast Cell Activation Syndrome (MCAS), Endothelial Dysfunction and microclots/thrombosis?

By
Update: New Research Builds on Previous Findings Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2832234?utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamanetworkopen&utm_content=wklyforyou&utm_term=040925&adv= Conclusions: This recent cohort study builds upon earlier work by identifying COVID-related cytokine storm (COVID-CS) through common inflammation markers and comparing it with two other cytokine storm (CS) conditions: malignancy-associated hemophagocytic lymphohistiocytosis (MN-HLH) and CAR-T–associated cytokine release syndrome (CAR-T CRS) . Among the three groups, patients treated with CAR-T therapy showed the highest survival rates , in contrast to those with COVID-CS and MN-HLH. Interestingly, the study found that CAR-T CRS and COVID-CS share similar cytokine activation pathways , suggesting a comparable immune response mechanism. In c...
Read more

The Impact of Acids on Muscular and Vascular Systems: Potential Negative Outcomes

By
This is ongoing research, and updates will be included as soon as they become available. Acids, whether from external sources (like industrial chemicals) or internal imbalances (such as metabolic disorders), can have profound effects on both the muscular and vascular systems.   Exposure to strong acids or acid imbalances in the body can disrupt cellular function, cause tissue damage, and lead to systemic health problems. This article explores how acids can negatively impact muscular and vascular health, with an emphasis on both external exposure to corrosive acids and internal acid imbalances caused by metabolic disorders or genetic conditions. Since not everyone is affected by ME/CFS or COVID, it could be beneficial to test for genetic predispositions, such as amino acids, particularly fatty acids. 1. External Acid Exposure and Its Effects on Muscular and Vascular Systems 1.1. Muscular Effects Muscle tissue is highly sensitive to changes in pH, and exposure to strong acids ca...
Read more

Introduction to Adenosine and Tachycardia

By
What is Adenosine? Adenosine is a chemical found in human cells, existing in three forms: adenosine, adenosine monophosphate (AMP), and adenosine triphosphate (ATP). Adenosine is a chemical found in the body that plays many roles, including influencing heart rate and promoting sleep and relaxation. It is also used as a medication to manage certain types of tachycardia, particularly supraventricular tachycardia. Adenosine works by slowing the heart rate through its action on the cardiac tissue. Adenosine production in the body occurs through multiple pathways: Phosphorylation of Adenine: Adenine can be directly phosphorylated to form AMP (adenosine monophosphate), which is then converted to ATP, ADP, and finally adenosine through dephosphorylation reactions. Breakdown of ATP: Adenosine is primarily formed in the body through the breakdown of ATP, which releases energy. ATP can be dephosphorylated stepwise through the action of various enzymes: ATP is first converted to ADP (adeno...
Read more